Catalyst Wire Dossier Catalyst Wire Dossier

Separator 3D

Separator 3D · Penumbra Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Separator 3D, covering 2018-09-13 to 2018-09-13. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke [NA]

See pricing